{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:31:46Z","timestamp":1769355106590,"version":"3.49.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.yrtph.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T02:13:05Z","timestamp":1520561585000},"page":"102-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Integrating chemical, toxicological and clinical research to assess the potential of reducing health risks associated with cigarette smoking through reducing toxicant emissions"],"prefix":"10.1016","volume":"95","author":[{"given":"Kevin","family":"McAdam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Eldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2018.03.005_bib1","series-title":"SRNT Annual Meeting, Seattle,WA, Feb 5\u20138 2014","article-title":"Comparison of mouth level exposure to tar and nicotine in Russian smokers of regular and superslim king size cigarettes","author":"Ashley","year":"2014"},{"key":"10.1016\/j.yrtph.2018.03.005_bib2","series-title":"Department of Health and Ageing","author":"Australian Government","year":"2002"},{"key":"10.1016\/j.yrtph.2018.03.005_bib3","series-title":"Tobacco Production, Chemistry and Technology","first-page":"398","article-title":"Smoke chemistry","author":"Baker","year":"1999"},{"key":"10.1016\/j.yrtph.2018.03.005_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0160-4120(90)90117-O","article-title":"The origins and properties of environmental tobacco smoke","volume":"16","author":"Baker","year":"1990","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2018.03.005_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0049-3848(97)00031-5","article-title":"The influence of smoking on soluble adhesion molecules and endothelial cell markers","volume":"85","author":"Blann","year":"1997","journal-title":"Thromb. Res."},{"key":"10.1016\/j.yrtph.2018.03.005_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1260\/0263-6174.29.2.117","article-title":"Use of classical adsorption theory to understand the dynamic filtration of volatile toxicants in cigarette smoke by active carbons","volume":"29","author":"Branton","year":"2011","journal-title":"Adsorpt. Sci. Technol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1752-153X-5-15","article-title":"Reduction of aldehydes and hydrogen cyanide yields in mainstream cigarette smoke using an amine functionalised ion exchange resin","volume":"5","author":"Branton","year":"2011","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.yrtph.2018.03.005_bib8","series-title":"Understanding the Risks: Why Certain Nicotine Products Are Less Risky than Smoking","author":"British American Tobacco","year":"2017"},{"key":"10.1016\/j.yrtph.2018.03.005_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/tc.2007.024158","article-title":"Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal","volume":"17","author":"Burns","year":"2008","journal-title":"Tobac. Contr."},{"key":"10.1016\/j.yrtph.2018.03.005_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.yrtph.2015.05.023","article-title":"Empirical characterisation of ranges of mainstream smoke toxicant yields from contemporary cigarette products using quantile regression methodology","volume":"72","author":"Camacho","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1054\/plef.2002.0438","article-title":"Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis","volume":"67","author":"Chehne","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.yrtph.2018.03.005_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.atherosclerosis.2008.04.046","article-title":"Smoking and smoking cessation \u2013 the relationship between cardiovascular disease and lipoprotein metabolism: a review","volume":"201","author":"Chelland-Campbell","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yrtph.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yrtph.2004.12.002","article-title":"Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions","volume":"41","author":"Counts","year":"2005","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"25","key":"10.1016\/j.yrtph.2018.03.005_bib15","article-title":"Cumulative risk assessment of three aldehydes present in tobacco smoke: using margin of exposure (MOE) and mode of action (MOA) evaluations","volume":"126","author":"Cunningham","year":"2012","journal-title":"Toxicologist"},{"issue":"71","key":"10.1016\/j.yrtph.2018.03.005_bib16","article-title":"The combination of two novel tobacco blends and filter technologies to reduce the in vitro genotoxicity and cytotoxicity of prototype cigarettes","volume":"3","author":"Crooks","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib17","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2004.07.047","article-title":"Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis","volume":"44","author":"Deo","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/2193-1801-3-374","article-title":"Approaches for the design of reduced toxicant emission cigarettes","volume":"3","author":"Dittrich","year":"2014","journal-title":"Springer Plus"},{"key":"10.1016\/j.yrtph.2018.03.005_bib19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.2.4682.739","article-title":"Smoking and carcinoma of the lung: preliminary report","volume":"2","author":"Doll","year":"1950","journal-title":"BMJ"},{"issue":"7455","key":"10.1016\/j.yrtph.2018.03.005_bib20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/bmj.38142.554479.AE","article-title":"Mortality in relation to smoking: 50 years' observation on male British Doctors","volume":"328","author":"Doll","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.yrtph.2018.03.005_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.yrtph.2015.01.006","article-title":"Variation in tobacco and mainstream smoke toxicant yields from selected commercial cigarette products","volume":"71","author":"Eldridge","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.yrtph.2017.02.022","article-title":"Impact assessment of WHO TobReg proposals for mandated lowering of selected mainstream cigarette smoke toxicants","volume":"86","author":"Eldridge","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib24","series-title":"Statement on the Applicability of the Margin of Exposure Approach for the Safety Assessment of Impurities Which Are Both Genotoxic and Carcinogenic in Substances Added to Food\/feed","author":"European Food Safety Authority Scientific Committee","year":"2012"},{"key":"10.1016\/j.yrtph.2018.03.005_bib25","article-title":"European union tobacco product directive","volume":"2014","author":"EU","year":"2014","journal-title":"Tobacco product directive 2014\/40\/EU of the European parliament and of the council"},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2018.03.005_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/13547500902965047","article-title":"The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke","volume":"14","author":"Faux","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.yrtph.2018.03.005_bib27","series-title":"Guidance for industry and FDA staff: \u201charmful and potentially harmful constituents\u201d in tobacco products as used in section 904(e) of the Federal Food, Drug, and Cosmetic Act","author":"FDA","year":"2011"},{"key":"10.1016\/j.yrtph.2018.03.005_bib28","first-page":"1","article-title":"Guidance for industry: Modified risk tobacco product applications","author":"Food and Drug Administration","year":"2012","journal-title":"Draft guidance"},{"key":"10.1016\/j.yrtph.2018.03.005_bib29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.metabol.2004.04.005","article-title":"F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control","volume":"53","author":"Flores","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.yrtph.2018.03.005_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/tc.12.4.424","article-title":"Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke","volume":"12","author":"Fowles","year":"2003","journal-title":"Tobac. Contr."},{"key":"10.1016\/j.yrtph.2018.03.005_bib31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0195-668X(03)00260-4","article-title":"Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994\/95)","volume":"24","author":"Fr\u00f6hlich","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yrtph.2018.03.005_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ntr\/ntq235","article-title":"Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study","volume":"13","author":"Frost-Pineda","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.yrtph.2018.03.005_bib33","first-page":"117","article-title":"The UK smoke constituents testing study. Summary of results and comparison with other studies","volume":"21","author":"Gregg","year":"2004","journal-title":"Beitr. Tabakforsch. Int."},{"key":"10.1016\/j.yrtph.2018.03.005_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2011.168559","article-title":"Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the coronary artery risk development in young adults study","volume":"58","author":"Gross","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.yrtph.2018.03.005_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1520-037X.2007.05957.x","article-title":"Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women","volume":"10","author":"Hammett","year":"2007","journal-title":"Prev. Cardiol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/1354750X.2014.912354","article-title":"A cross-sectional analysis of candidate biomarkers of biological effect in smokers, never-smokers and ex-smokers","volume":"19","author":"Haswell","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.yrtph.2018.03.005_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5551\/jat1994.7.177","article-title":"Life-style and serum lipids and lipoproteins","volume":"7","author":"Hata","year":"2000","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.yrtph.2018.03.005_bib38","series-title":"Constituents and Emissions Reported for Cigarettes Sold in Canada \u2013 2004","author":"Health Canada","year":"2004"},{"key":"10.1016\/j.yrtph.2018.03.005_bib39","series-title":"Chemical Carcinogenesis and Mutagenesis","article-title":"Chapter 3: advances in tobacco carcinogenesis","author":"Hoffmann","year":"1990"},{"key":"10.1016\/j.yrtph.2018.03.005_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/009841097160393","article-title":"The changing cigarette, 1950-1995","volume":"50","author":"Hoffmann","year":"1997","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.yrtph.2018.03.005_bib41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1248\/bpb.b16-00025","article-title":"Carbonyl compounds in the gas phase of cigarette mainstream smoke and their pharmacological properties","volume":"39","author":"Horinouchi","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.yrtph.2018.03.005_bib42","series-title":"Scientific Standards for Studies on Modified Risk Tobacco Products","author":"Institute of Medicine","year":"2011"},{"key":"10.1016\/j.yrtph.2018.03.005_bib43","first-page":"161","article-title":"Determination of \u201cHoffmann analytes\u201d in cigarette mainstream smoke. The CORESTA 2006 joint experiment","volume":"23","author":"Intorp","year":"2009","journal-title":"Beitr. Tabakforsch. Int."},{"key":"10.1016\/j.yrtph.2018.03.005_bib44","series-title":"4387, 2000. International Organization for Standardization. Cigarettes\u2014determination of Total and Nicotine-free Dry Particulate Matter Using a Routine Analytical Smoking Machine","author":"ISO","year":"2011"},{"key":"10.1016\/j.yrtph.2018.03.005_bib45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1253\/circj.68.671","article-title":"Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis","volume":"68","author":"Kusano","year":"2004","journal-title":"Circ. J."},{"key":"10.1016\/j.yrtph.2018.03.005_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.atherosclerosis.2008.06.028","article-title":"Smoking, smoking cessation and inflammatory markers in older Chinese men: the Guangzhou Biobank Cohort Study","volume":"203","author":"Lao","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yrtph.2018.03.005_bib47","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.fct.2011.02.015","article-title":"The use of a novel tobacco treatment process to reduce toxicant yields in cigarette smoke","volume":"49","author":"Liu","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157019311797440272","article-title":"Some recent topics in cigarette smoke science","volume":"8","author":"Liu","year":"2011","journal-title":"Mini-Reviews Org. Chem."},{"key":"10.1016\/j.yrtph.2018.03.005_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/CCLM.2009.069","article-title":"Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers","volume":"47","author":"Lowe","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.yrtph.2018.03.005_bib50","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.chemrestox.6b00188","article-title":"Chemical composition of an e-cigarette aerosol \u2013 a quantitative comparison with cigarette smoke","volume":"29","author":"Margham","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fct.2011.04.002","article-title":"The use of a novel tobacco sheet and smoke dilution to reduce toxicant yields in cigarette smoke","volume":"49","author":"McAdam","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yrtph.2011.11.007","article-title":"Design and chemical evaluation of reduced machine-yield cigarettes","volume":"62","author":"McAdam","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2018.03.005_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1752-153X-7-151","article-title":"Polycyclic aromatic hydrocarbons in US and Swedish smokeless tobacco products","volume":"7","author":"McAdam","year":"2013","journal-title":"Chem. Cent. J."},{"issue":"13","key":"10.1016\/j.yrtph.2018.03.005_bib54","article-title":"Analysis of hydrazine in smokeless tobacco products by gas chromatography - mass spectrometry","volume":"9","author":"McAdam","year":"2015","journal-title":"Chem. Cent. J."},{"issue":"9","key":"10.1016\/j.yrtph.2018.03.005_bib55","first-page":"13","article-title":"The acrylamide content of smokeless tobacco products","volume":"2015","author":"McAdam","year":"2016","journal-title":"Chem. Cent. J."},{"issue":"131","key":"10.1016\/j.yrtph.2018.03.005_bib56","article-title":"Comprehensive survey of radionuclides in contemporary smokeless tobacco products","volume":"11","author":"McAdam","year":"2017","journal-title":"Chemistry Central"},{"key":"10.1016\/j.yrtph.2018.03.005_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0269881112458731","article-title":"Reducing harm from tobacco use","volume":"27","author":"McNeill","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"Suppl. l","key":"10.1016\/j.yrtph.2018.03.005_bib58","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1080\/13547500500216546","article-title":"F2-isoprostanes as markers of oxidative stress in vivo: an overview","volume":"10","author":"Milne","year":"2005","journal-title":"Biomarkers"},{"key":"10.1016\/j.yrtph.2018.03.005_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0027-5107(77)90175-0","article-title":"Relation between chemical constituents of tobacco and mutagenic activity of cigarette smoke condensate","volume":"48","author":"Mizusaki","year":"1977","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2018.03.005_bib60","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage","volume":"332","author":"Morrow","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2018.03.005_bib61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.CIR.76.1.6","article-title":"Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes","volume":"76","author":"Nowak","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.yrtph.2018.03.005_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2013.08.015","article-title":"Identification of stable cytotoxic factors in the gas phase extract of cigarette smoke and pharmacological characterization of their cytotoxicity","volume":"314","author":"Noya","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2018.03.005_bib63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ypmed.2005.02.002","article-title":"CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers","volume":"41","author":"Ohsawa","year":"2005","journal-title":"Prev. Med."},{"key":"10.1016\/j.yrtph.2018.03.005_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1024\/0301-1526.29.2.103","article-title":"Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults","volume":"29","author":"Oguogho","year":"2000","journal-title":"Vasa"},{"key":"10.1016\/j.yrtph.2018.03.005_bib65","doi-asserted-by":"crossref","DOI":"10.1089\/aivt.2016.0038","article-title":"Assessment of acute in vitro human cellular responses to smoke extracts from a reduced toxicant prototype cigarette","volume":"3","author":"Oke","year":"2017","journal-title":"Applied In Vitro Toxicol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/dc09-0763","article-title":"Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals","volume":"32","author":"Piemonti","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yrtph.2018.03.005_bib67","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.fct.2017.05.022","article-title":"A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 1): product operation and preliminary aerosol chemistry assessment","volume":"106","author":"Poynton","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/CBB:43:1:167","article-title":"Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms","volume":"43","author":"Rahman","year":"2005","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.yrtph.2018.03.005_bib69","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.ATV.13.6.777","article-title":"Excretion of thromboxane metabolites in healthy women after cessation of smoking","volume":"13","author":"R\u00e5ngemark","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.yrtph.2018.03.005_bib70","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/0091270008315316","article-title":"A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system","volume":"48","author":"Roethig","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib71","series-title":"Smoking and Health: a Report of the Royal College of Physicians on Smoking in Relation to Cancer of the Lung and Other Diseases","author":"Royal College of Physicians","year":"1962"},{"key":"10.1016\/j.yrtph.2018.03.005_bib72","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s002100100398","article-title":"Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man","volume":"363","author":"Saareks","year":"2001","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib73","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.yrtph.2016.10.001","article-title":"Evaulation of the tobacco heating system 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol","volume":"81","author":"Schaller","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yrtph.2013.02.007","article-title":"Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes","volume":"66","author":"Shepperd","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib75","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/1471-2458-13-690","article-title":"A single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes","volume":"13","author":"Shepperd","year":"2013","journal-title":"BMC Publ. Health"},{"issue":"2","key":"10.1016\/j.yrtph.2018.03.005_bib76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yrtph.2015.04.016","article-title":"Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes","volume":"72","author":"Shepperd","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2018.03.005_bib77","series-title":"Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction","article-title":"Committee to assess the science base for tobacco harm reduction, board on health promotion and disease prevention","year":"2001"},{"key":"10.1016\/j.yrtph.2018.03.005_bib78","series-title":"The Health Consequences of Smoking\u201450 Years of Progress: a Report of the Surgeon General","author":"US Department of Health and Human Services","year":"2014"},{"key":"10.1016\/j.yrtph.2018.03.005_bib79","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/01.CIR.83.5.1698","article-title":"Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men","volume":"83","author":"Wennmalm","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.yrtph.2018.03.005_bib80","series-title":"Report on the Scientific Basis of Tobacco Product Regulation","first-page":"57","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.yrtph.2018.03.005_bib81","series-title":"2015, World Health Organisation Report on the Scientific Basis of Tobacco Product Regulations: Fifth Report of a WHO Study Group","author":"World Health Organisation","year":"2015"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230018300746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230018300746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:07:46Z","timestamp":1535022466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230018300746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":79,"alternative-id":["S0273230018300746"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2018.03.005","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating chemical, toxicological and clinical research to assess the potential of reducing health risks associated with cigarette smoking through reducing toxicant emissions","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}